Preclinical development of a vaccine 'against smoking'

Onkologie

Volumn 25, Issue 5, 2002, Pages 406-411

  Cerny, E H ^a   Levy R ^a   Mauel, J ^b   Mpandi, M ^c   Mutter, M ^d   Henzelin Nkubana, C ^d   Patiny, L ^d   Tuchscherer G , ^d   Cerny, T ^e  

^a Chilka Ltd   (Switzerland)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c R and D   (Switzerland)

^d EPFL   (Switzerland)

^e Kantonsspital St Gallen ^*  (Switzerland)

Author keywords

Antibody; Nicotine; Vaccination

Indexed keywords

ANTIBODY; CARRIER PROTEIN; CHOLERA TOXIN B SUBUNIT; IMMUNOGLOBULIN G; NICOTINE; POLYCLONAL ANTIBODY; VACCINE;

ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; BRAIN; CIGARETTE SMOKING; CONTROLLED STUDY; IMMUNIZATION; IMPLANTATION; ISOTOPE LABELING; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; SALIVA; SIMULATION; SMOKING; TIME;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; CARRIER PROTEINS; CHOLERA TOXIN; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFUSION PUMPS; MICE; MICE, INBRED BALB C; NICOTINE; SMOKING; SMOKING CESSATION; TOBACCO USE DISORDER; VACCINES, SYNTHETIC;

EID: 0036976430     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000067433     Document Type: Article

References (25)

1. Bartecchi CE, MacKenzie TD, Schrier RW: The global tobacco epidemic. Sci Am 1995;272:44-51.
2. MacKenzie TD, Bartecchi CE, Schrier RW: The human costs of tobacco use (2). N Engl J Med 1994;330:975-980.
3. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Wolf AP, Warner D, Cilento R, Zezulkova I: Neuropharmacological actions of cigarette smoke: Brain monoamine oxidase B (MAO B) inhibition. J Addict Dis 1998;17:23-34.
4. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R: Inhibition of monoamine oxidase B in the brains of smokers. Nature 1996;379:733-736.
5. Wise RA: Neurobiology of addiction. Curr Opin Neurobiol 1996;6:243-251.
6. Chiamulera C, Epping-Jordan MP, Zocchi A, Marcon C, Cottiny C, Tacconi S, Corsi M, Orzi F, Conquet F: Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nat Neurosci 2001;4:873-874.
7. Cornish JL, Kalivas PW: Cocaine sensitization and craving: Differing roles for dopamine and glutamate in the nucleus accumbens. J Addict Dis 2001;20: 43-54.
8. Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR: Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature 1974;252:708-710.
9. Wainer BH, Fitch FW, Rothberg RM, Fried J: Morphine-3-succinyl-bovine serum albumin: An immunogenic hapten-protein conjugate. Science 1972;176:1143-1145.
10. Wainer BH, Fitch FW, Rothberg RM, Fried J: The structure of morphine monohemisuccinate. Science 1972;178:647-648.
11. Cerny EH: Vaccine and Immune Serum against Drugs Of Abuse. Patent WO 92/03163, 1990.
12. Langone JJ, Gjika HB, Van Vunakis H: Nicotine and its metabolites. Radioimmunoassays for nicotine and cotinine. Biochemistry 1973;12:5025-5030.
13. Langone JJ, Van Vunakis H: Radioimmunoassay of nicotine, cotinine, and gamma-(3-pyridyl)-gamma-oxo-N-methylbutyramide. Methods Enzymol 1982;84:628-640.
14. Castro A, Prieto I: Nicotine antibody production: Comparison of two nicotine conjugates in different animal species. Biochem Biophys Res Commun 1975;67:583-589.
15. Bergquist C, Johansson EL, Lagergard T, Holmgren J, Rudin A: Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun 1997;65:2676-2684.
16. Bergquist C, Lagergard T, Holmgren J: Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid. Apmis 1998;106:800-806.
17. Rudin A, Johansson EL, Bergquist C, Holmgren J: Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect Immun 1998;66:3390-3396.
18. Gorrod JW, Jacob P (eds): Analytic Determination of Nicotine and Related Compounds and Their Metabolites. Amsterdam, Elsevier, 1999, pp 69-135.
19. Crooks PA, Godin CS, Pool WF: Enantiomeric purity of nicotine in tobacco smoke. Med Sci Res 1992;20:879-880.
20. Muller R: Determination of affinity and specificity of anti-hapten antibodies by competitive radioimmunoassay. Methods Enzymol 1983;92:589-601.
21. Kaliss N, Pressman D: Plasma and blood volumes of mouse organs, as determined with radioactive iodoproteins. Proc Soc Exp And Med 1950;75:16-20.
22. Hieda Y, Keyler DE, Vandevoort JT, Kane JK, Ross CA, Raphael DE, Niedbalas RS, Pentel PR: Active immunization alters the plasma nicotine concentration in rats. J Pharmacol Exp Ther 1997;283:1076-1081.
23. Hieda Y, Keyler DE, Ennifar S, Fattom A, Pentel PR: Vaccination against nicotine during continued nicotine administration in rats: Immunogenicity of the vaccine and effects on nicotine distribution to brain. Int J Immunopharmacol 2000;22:809-819.
24. Killian, A, Bonese K, Rothberg RM, Wainer BH, Schuster CR: Effects of passive immunization against morphine on heroin self-administration. Pharmacol Biochem Behav 1978;9:347-352.
25. Unanue ER, Benacerraf B: Textbook of Immunology. London, Williams and Wilkins, 1984, p 188.